| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $995.6M | +18.6% |
| Cost of Revenue | $179.0M | +18.1% |
| Gross Profit | $816.6M | +18.8% |
| R&D Expense | $146.3M | +10.5% |
| SG&A Expense | $138.4M | +21.4% |
| Operating Income | $73.7M | -2.1% |
| Pre-tax Income | $81.1M | -3.1% |
| Income Tax | $4.9M | +105.8% |
| Net Income | $76.1M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $302.1M | -3.4% |
| Accounts Receivable | $252.0M | +13.2% |
| Current Assets | $635.1M | +6.7% |
| Total Assets | $1.12B | +18.5% |
| Current Liabilities | $555.0M | +14.5% |
| Stockholders' Equity | $325.1M | +16.9% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $207.4M | +1.8% |
| Capital Expenditures | $3.8M | -8.1% |
| Investing Cash Flow | -$70.4M | -1175.1% |
| Financing Cash Flow | -$147.8M | +13.3% |
| Free Cash Flow | $203.6M | +2.0% |
| -54.9% |
| EPS (Basic) | $1.74 | -54.8% |
| EPS (Diluted) | $1.68 | -55.2% |